Dr. Stephanie Sellers is an Assistant Professor in the Division of Cardiology at the University of British Columbia and Director of the Cardiovascular Translational Laboratory. She also leads the Cardiovascular Pathology Core Lab at DCI. Her multidisciplinary research program bridges molecular biology, pathology, imaging, and device evaluation, with a particular focus on the mechanisms of bioprosthetic valve degeneration, transcatheter heart valve durability, and reintervention strategies. Dr. Sellers’ group also leads a global registry and biobank of explanted transcatheter heart valves and partners with industry and academia to advance valve science through benchtop modeling, investigation mechanisms impacting device durability, and creation of educational opportunities to advance cross-interdisciplinary learning for scientists, engineers, allied health team members, and clinicians.
Dr. Sellers is Michael Smith Health Research BC Scholar and the recipient of the 2023 UBC Department of Medine Martin M Hoffman Award for Excellence in Research, the 2024 UBC Faculty of Medicine Distinguished Achievement Award – Excellence in Basic Science Research, and the 2025 St. Paul’s Hospital Department of Medicine Faculty Research Award. The author of over 150 peer-reviewed publications and a recipient of multiple national and international grants, Dr. Sellers She holds editorial board appointments with JACC Case Reports, Cardiovascular Pathology, the Journal of the Heart Valve Society, and Structural Heart.
